Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product Type

  2.3.2 Market Size By Application

  2.3.3 Market Size By Procedure Type

  2.3.4 Market Size By Cancer Type

 2.3.5 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

   3.4.1 Needles, imaging components, biomaterials, reagents, and device component suppliers

3.4.2 Biopsy needles, instruments, imaging, and tissue sampling device manufacturers

3.4.3 Medical device distributors and diagnostic equipment suppliers

3.4.4 Hospitals, cancer centers, diagnostic laboratories, and specialty clinics

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 Biopsy Type & Procedure Metrics

4.1.1 Share (%) of cancer biopsy procedures across needle biopsy, surgical biopsy, liquid biopsy, and image-guided biopsy techniques.

4.1.2 Growth (%) in cancer biopsy procedure volumes during 2025 and 2026.

4.1.3 Increase (%) in minimally invasive and image-guided biopsy adoption across oncology diagnostics.

4.1.4 Share (%) of biopsy procedures performed for initial diagnosis, staging, treatment selection, and recurrence monitoring.

4.2 Cancer Type & Diagnostic Metrics

4.2.1 Share (%) of cancer biopsy demand across breast, lung, prostate, colorectal, liver, and other cancers.

4.2.2 Growth (%) in biopsy utilization for early cancer detection and molecular characterization.

4.2.3 Increase (%) in tissue and liquid biopsy testing for biomarker identification and precision oncology.

4.2.4 Improvement (%) in diagnostic accuracy, sample adequacy, and cancer subtype identification through advanced biopsy techniques.

4.3 End-User & Laboratory Metrics

4.3.1 Share (%) of cancer biopsy procedures across hospitals, diagnostic laboratories, cancer centers, and ambulatory surgical centers.

4.3.2 Growth (%) in pathology and molecular testing volumes linked to biopsy samples.

4.3.3 Increase (%) in integration of biopsy workflows with genomic testing, immunohistochemistry, and companion diagnostics.

4.3.4 Reduction (%) in sample processing time, repeat biopsies, and diagnostic turnaround through streamlined laboratory workflows.

4.4 Technology & Innovation Metrics

4.4.1 Share (%) of cancer biopsy platforms incorporating AI-assisted pathology, digital imaging, robotics, and advanced molecular diagnostics.

4.4.2 Growth (%) in liquid biopsy, circulating tumor DNA, and next-generation sequencing applications.

4.4.3 Increase (%) in biomarker sensitivity, mutation detection, and real-time treatment monitoring capabilities.

4.4.4 Reduction (%) in procedural invasiveness, diagnostic delays, tissue requirements, and patient recovery time through advanced biopsy technologies.

5. Cancer Biopsy Market Segmental Analysis & Forecast, By Product Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Instruments

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Kits and Consumables

 5.4 Services

6. Cancer Biopsy Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Cancer Diagnosis and Staging

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Treatment Monitoring

 6.4 Cancer Screening

7. Cancer Biopsy Market Segmental Analysis & Forecast, By Procedure Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Tissue Biopsies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Liquid Biopsy

 7.4 Others

8. Cancer Biopsy Market Segmental Analysis & Forecast, By Cancer Type, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Breast Cancer

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Lung Cancer

 8.4 Colorectal Cancer

 8.5 Blood Cancer

 8.6 Prostate Cancer

 8.7 Pancreatic Cancer

 8.8 Others

9. Cancer Biopsy Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospitals

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 Ambulatory Surgical Centers 

  9.4 Diagnostic Laboratories 

  9.5 Cancer Research Institutes 

10. Cancer Biopsy Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Cancer Biopsy Market Size & Forecast, By Product Type, 2022–2035

  10.2.3 Cancer Biopsy Market Size & Forecast, By Application, 2022–2035

  10.2.4 Cancer Biopsy Market Size & Forecast, By Procedure Type, 2022–2035

  10.2.5 Cancer Biopsy Market Size & Forecast, By Cancer Type, 2022–2035

  10.2.6 Cancer Biopsy Market Size & Forecast, By End User, 2022–2035

  10.2.7 Cancer Biopsy Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Cancer Biopsy Market Size & Forecast, By Product Type, 2022–2035

 10.3.3 Cancer Biopsy Market Size & Forecast, By Application, 2022–2035

 10.3.4 Cancer Biopsy Market Size & Forecast, By Procedure Type, 2022–2035

 10.3.5 Cancer Biopsy Market Size & Forecast, By Cancer Type, 2022–2035

 10.3.6 Cancer Biopsy Market Size & Forecast, By End User, 2022–2035

 10.3.7 Cancer Biopsy Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Cancer Biopsy Market Size & Forecast, By Product Type, 2022–2035

 10.4.3 Cancer Biopsy Market Size & Forecast, By Application, 2022–2035

 10.4.4 Cancer Biopsy Market Size & Forecast, By Procedure Type, 2022–2035

 10.4.5 Cancer Biopsy Market Size & Forecast, By Cancer Type, 2022–2035

 10.4.6 Cancer Biopsy Market Size & Forecast, By End User, 2022–2035

 10.4.7 Cancer Biopsy Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Cancer Biopsy Market Size & Forecast, By Product Type, 2022–2035

 10.5.3 Cancer Biopsy Market Size & Forecast, By Application, 2022–2035

 10.5.4 Cancer Biopsy Market Size & Forecast, By Procedure Type, 2022–2035

 10.5.5 Cancer Biopsy Market Size & Forecast, By Cancer Type, 2022–2035

 10.5.6 Cancer Biopsy Market Size & Forecast, By End User, 2022–2035

 10.5.7 Cancer Biopsy Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Cancer Biopsy Market Size & Forecast, By Product Type, 2022–2035

 10.6.3 Cancer Biopsy Market Size & Forecast, By Application, 2022–2035

 10.6.4 Cancer Biopsy Market Size & Forecast, By Procedure Type, 2022–2035

 10.6.5 Cancer Biopsy Market Size & Forecast, By Cancer Type, 2022–2035

 10.6.6 Cancer Biopsy Market Size & Forecast, By End User, 2022–2035

 10.6.7 Cancer Biopsy Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 South Africa

  10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Year-Wise Strategies & Development, 2022 – 2026

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

 11.6.1 Becton, Dickinson and Company

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

         11.6.1.4 Geographical Presence

  11.6.1.5 SWOT Analysis

 11.6.2 Hologic, Inc.

11.6.3 Danaher Corporation

11.6.4 Thermo Fisher Scientific Inc.

11.6.5 Roche Holding AG

11.6.6 Guardant Health, Inc.

11.6.7 Exact Sciences Corporation

11.6.8 Illumina, Inc.

11.6.9 Merit Medical Systems, Inc.

11.6.10 Argon Medical Devices, Inc.

11.6.11 Boston Scientific Corporation

11.6.12 Cook Medical LLC

11.6.13 CONMED Corporation

11.6.14 Devicor Medical Products, Inc. (Mammotome)

11.6.15 Medtronic plc

11.6.16 Cardinal Health, Inc.

11.6.17 Olympus Corporation

11.6.18 Fujifilm Holdings Corporation

11.6.19 Bio-Rad Laboratories, Inc.

11.6.20 Natera, Inc.

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures